Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

Wouter Froyman, D. Timmerman, S. Guerriero et al.|The Lancet Oncology|2019

Cited by 188